Bristol-Myers Squibb completes $20M investment in Compugen

seekingalpha2021-11-11

Compugen(NASDAQ:CGEN)shares are trading ~17.5% higher in the pre-market after announcing that Bristol-Myers Squibb(NYSE:BMY)has completed its $20M in the company. The investment follows the issuance ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

AliPharma
2021-11-11
AliPharma
ok
- AliPharma:
  ok
咩咩虎
2021-11-11
咩咩虎
Ok
HoSeyLiao48
2021-11-11
HoSeyLiao48
[财迷] [强] [看涨]
Planter26
2021-11-11
Planter26
[强]
YYKTAN
2021-11-11
YYKTAN
Latest
Alannjy
2021-11-11
Alannjy
Like
- YYKTAN:
  ok
- Txfen80:
  Ok
- JiaJun87:
  [What][Miser]

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1171270648?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-11 20:36","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1171270648","market":"us","top_or_hot":-1,"title":"Bristol-Myers Squibb completes $20M investment in Compugen","media":"seekingalpha","content":"<div>\n<p>Compugen(NASDAQ:CGEN)shares are trading ~17.5% higher in the pre-market after announcing that Bristol-Myers Squibb(NYSE:BMY)has completed its $20M in the company.\nThe investment follows the issuance ...</p>\n\n<a href=\"https://seekingalpha.com/news/3769400-bristol-myers-squibb-completes-20m-investment-in-compugen\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bristol-Myers Squibb completes $20M investment in Compugen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBristol-Myers Squibb completes $20M investment in Compugen\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 20:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3769400-bristol-myers-squibb-completes-20m-investment-in-compugen><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Compugen(NASDAQ:CGEN)shares are trading ~17.5% higher in the pre-market after announcing that Bristol-Myers Squibb(NYSE:BMY)has completed its $20M in the company.\nThe investment follows the issuance ...</p>\n\n<a href=\"https://seekingalpha.com/news/3769400-bristol-myers-squibb-completes-20m-investment-in-compugen\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/3769400-bristol-myers-squibb-completes-20m-investment-in-compugen","article_id":"1171270648","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171270648","pubTimestamp":1636634175,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Compugen(NASDAQ:CGEN)shares are trading ~17.5% higher in the pre-market after announcing that Bristo","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"施贵宝完成2000万美元对Compugen的投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMY":0.9,"CGEN":0.9},"content_text":"Compugen(NASDAQ:CGEN)shares are trading ~17.5% higher in the pre-market after announcing that Bristol-Myers Squibb(NYSE:BMY)has completed its $20M in the company.\nThe investment follows the issuance of ~2.3M Compugen shares purchased by Bristol-Myers at ~$8.57 per share, indicating a 33% premium over the closing price on Nov. 09.\nIn addition to the existing joint development committee at the operating level, a joint steering committee has been set up as part of the expansion of collaboration to oversee the programs that come under the partnership.\n\"Bristol Myers Squibb's strategic investment in Compugen strengthens our relationship and the goal of both companies to take forward our clinical studies conducted under our collaboration in bringing innovative therapies to cancer patients,” Compugen (CGEN) CEO Anat Cohen-Dayag said.\nIn 2018, Bristol-Myers (BMY) teamed up with Compugen (CGEN) to evaluate anti-PVRIG antibody COM701 in combination with Opdivo (nivolumab) in patients with advanced solid tumors.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":870400200,"gmtCreate":1636640156882,"gmtModify":1636640157050,"author":{"id":"3586596744781365","authorId":"3586596744781365","name":"AliPharma","avatar":"https://static.tigerbbs.com/4ae50feeb2edce44d991e8e753fb37e5","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3586596744781365","idStr":"3586596744781365"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870400200","repostId":1171270648,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538927,"gmtCreate":1636640166428,"gmtModify":1636640166509,"authorId":3586596744781365,"author":{"id":3586596744781365,"idStr":"3586596744781365","authorId":3586596744781365,"name":"AliPharma","avatar":"https://static.tigerbbs.com/4ae50feeb2edce44d991e8e753fb37e5","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870400200,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":870544147,"gmtCreate":1636639116630,"gmtModify":1636639116984,"author":{"id":"3568542354994015","authorId":"3568542354994015","name":"咩咩虎","avatar":"https://static.tigerbbs.com/a6663bef57eca539a2c52ea184964654","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3568542354994015","idStr":"3568542354994015"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870544147","repostId":1171270648,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":870554055,"gmtCreate":1636637893492,"gmtModify":1636637945676,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087949413245130","idStr":"4087949413245130"},"htmlText":"[财迷]&nbsp;[强]&nbsp;[看涨]&nbsp;","listText":"[财迷]&nbsp;[强]&nbsp;[看涨]&nbsp;","text":"[财迷] [强] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870554055","repostId":1171270648,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":870551490,"gmtCreate":1636637482531,"gmtModify":1636637482654,"author":{"id":"3585783194028665","authorId":"3585783194028665","name":"Planter26","avatar":"https://static.tigerbbs.com/fcd3eb7e0dd9f8d851b3706f08d50bd4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3585783194028665","idStr":"3585783194028665"},"htmlText":"[强]&nbsp;","listText":"[强]&nbsp;","text":"[强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870551490","repostId":1171270648,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":870520016,"gmtCreate":1636635932152,"gmtModify":1636635932784,"author":{"id":"3586858995147972","authorId":"3586858995147972","name":"YYKTAN","avatar":"https://static.tigerbbs.com/e9c7bf12299d79e1cacc0c24919b7a3c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3586858995147972","idStr":"3586858995147972"},"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870520016","repostId":1171270648,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":870562249,"gmtCreate":1636635647166,"gmtModify":1636635860158,"author":{"id":"3572213696829638","authorId":"3572213696829638","name":"Alannjy","avatar":"https://static.tigerbbs.com/ab326ac9056e88557b36f97dfdad9cac","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3572213696829638","idStr":"3572213696829638"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/870562249","repostId":1171270648,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538238,"gmtCreate":1636635926372,"gmtModify":1636635926409,"authorId":3586858995147972,"author":{"id":3586858995147972,"idStr":"3586858995147972","authorId":3586858995147972,"name":"YYKTAN","avatar":"https://static.tigerbbs.com/e9c7bf12299d79e1cacc0c24919b7a3c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870562249,"type":1,"supId":6538214,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":6538214,"gmtCreate":1636635804630,"gmtModify":1636635804733,"authorId":3586489129629376,"author":{"id":3586489129629376,"idStr":"3586489129629376","authorId":3586489129629376,"name":"Txfen80","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870562249,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6538212,"gmtCreate":1636635798946,"gmtModify":1636635799050,"authorId":3573875235773606,"author":{"id":3573875235773606,"idStr":"3573875235773606","authorId":3573875235773606,"name":"JiaJun87","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870562249,"type":1,"supId":0,"prevId":0,"content":"[What][Miser]","text":"[What][Miser]","html":"[What][Miser]"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":59,"commentSize":12,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171270648"}